These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30721063)

  • 1. Allosteric Modalities for Membrane-Bound Receptors: Insights from Drug Hunting for Brain Diseases.
    Coughlin Q; Hopper AT; Blanco MJ; Tirunagaru V; Robichaud AJ; Doller D
    J Med Chem; 2019 Jul; 62(13):5979-6002. PubMed ID: 30721063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
    Congreve M; Oswald C; Marshall FH
    Trends Pharmacol Sci; 2017 Sep; 38(9):837-847. PubMed ID: 28648526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allosteric modulator of GPCRs and new drug targets].
    Wei RS; He SP
    Sheng Li Ke Xue Jin Zhan; 2012 Dec; 43(6):459-62. PubMed ID: 23520767
    [No Abstract]   [Full Text] [Related]  

  • 4. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
    Müller CE; Schiedel AC; Baqi Y
    Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulation of kinases and GPCRs: design principles and structural diversity.
    Lewis JA; Lebois EP; Lindsley CW
    Curr Opin Chem Biol; 2008 Jun; 12(3):269-80. PubMed ID: 18342020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugability of extracellular targets: discovery of small molecule drugs targeting allosteric, functional, and subunit-selective sites on GPCRs and ion channels.
    Grigoriadis DE; Hoare SR; Lechner SM; Slee DH; Williams JA
    Neuropsychopharmacology; 2009 Jan; 34(1):106-25. PubMed ID: 18800070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What have we learned from single ion channels?
    Colquhoun D
    J Physiol; 2007 Jun; 581(Pt 2):425-7. PubMed ID: 17363381
    [No Abstract]   [Full Text] [Related]  

  • 9. Allosteric modulation of G protein-coupled receptors: perspectives and recent developments.
    Soudijn W; Van Wijngaarden I; IJzerman AP
    Drug Discov Today; 2004 Sep; 9(17):752-8. PubMed ID: 15450241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [G-protein-coupled receptors targeting: the allosteric approach].
    Sebag JA; Pantel J
    Med Sci (Paris); 2012 Oct; 28(10):845-51. PubMed ID: 23067415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation of G protein-coupled receptors.
    May LT; Leach K; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCR allosterism and accessory proteins: new insights into drug discovery, 17 July 2004, Glasgow, Scotland.
    Henry B
    IDrugs; 2004 Sep; 7(9):819-21. PubMed ID: 15470594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Measure of Receptor Agonist and Modulator Equi-Response and Equi-Occupancy Selectivity.
    Zhang R; Kavana M
    Sci Rep; 2016 Apr; 6():25158. PubMed ID: 27116909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Quantitative Characterization of Functional Allosteric Effects.
    Kenakin T
    Curr Protoc Pharmacol; 2017 Mar; 76():9.22.1-9.22.10. PubMed ID: 28306151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When simple agonism is not enough: emerging modalities of GPCR ligands.
    Smith NJ; Bennett KA; Milligan G
    Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging opportunities for allosteric modulation of G-protein coupled receptors.
    Wang CI; Lewis RJ
    Biochem Pharmacol; 2013 Jan; 85(2):153-62. PubMed ID: 22975406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of receptor allosterism and its implication for drug discovery.
    Zhang R; Kavana M
    Expert Opin Drug Discov; 2015 Jul; 10(7):763-80. PubMed ID: 25927503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular insights into allosteric modulation of Class C G protein-coupled receptors.
    Leach K; Gregory KJ
    Pharmacol Res; 2017 Feb; 116():105-118. PubMed ID: 27965032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family B G Protein-coupled Receptors and their Ligands: From Structure to Function.
    Liapakis G; Matsoukas MT; Karageorgos V; Venihaki M; Mavromoustakos T
    Curr Med Chem; 2017; 24(31):3323-3355. PubMed ID: 28266266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.